Evofem Biosciences Inc

NASDAQ:EVFM   11:34:24 AM EDT
0.42
+0.01 (+1.29%)
Earnings Announcements

Evofem Biosciences Reports Q3 Loss Per Share $0.48

Published: 11/15/2021 21:38 GMT
Evofem Biosciences Inc (EVFM) - Evofem Biosciences Reports Third Quarter 2021 Financial Results and Provides Corporate Update.
Q3 Loss per Share $0.48.
Q4 Earnings per Share View $-0.35 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $2.75 Million
Adjusted EPS is expected to be -$0.26

Next Quarter Revenue Guidance is expected to be $4.9 Million
Next Quarter EPS Guidance is expected to be -$0.16

More details on our Analysts Page.